FDA Sues to Stop Stem Cell Clinics From Using Unapproved Treatments

The Food and Drug Administration is seeking a permanent injunction to stop two stem cell clinics from treating patients with stem cell products for serious health conditions and diseases, claiming that the treatments were marketed without proof of safety from the FDA, according to complaints filed Wednesday in federal court.

Read more

Class Claims Tersaro Stock Plunged After Revealing Cancer Drug’s Risks

Shareholders of biopharmaceutical company Tesaro Inc. claim in a class action that the company covered up health risks associated with a cancer drug until forced by the U.S. Food and Drug Administration to report the drug’s serious adverse effects.

Read more